These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27527802)

  • 1. Rates and patterns of recurrence after curative intent resection for gallbladder cancer: a multi-institution analysis from the US Extra-hepatic Biliary Malignancy Consortium.
    Margonis GA; Gani F; Buettner S; Amini N; Sasaki K; Andreatos N; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
    HPB (Oxford); 2016 Nov; 18(11):872-878. PubMed ID: 27527802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.
    Kim WS; Choi DW; You DD; Ho CY; Heo JS; Choi SH
    J Gastrointest Surg; 2010 Apr; 14(4):679-87. PubMed ID: 20094817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival.
    Choi SB; Han HJ; Kim CY; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
    Hepatogastroenterology; 2012; 59(113):36-41. PubMed ID: 22251521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine port-site excision in incidentally discovered gallbladder cancer is not associated with improved survival: A multi-institution analysis from the US Extrahepatic Biliary Malignancy Consortium.
    Ethun CG; Postlewait LM; Le N; Pawlik TM; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick BA; Weber SM; Salem A; Martin RCG; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Cardona K; Maithel SK
    J Surg Oncol; 2017 Jun; 115(7):805-811. PubMed ID: 28230242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated NLR in gallbladder cancer and cholangiocarcinoma - making bad cancers even worse: results from the US Extrahepatic Biliary Malignancy Consortium.
    Beal EW; Wei L; Ethun CG; Black SM; Dillhoff M; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Pawlik TM; Scoggins C; Martin RC; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR
    HPB (Oxford); 2016 Nov; 18(11):950-957. PubMed ID: 27683047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.
    Lee W; Jeong CY; Jang JY; Kim YH; Roh YH; Kim KW; Kang SH; Yoon MH; Seo HI; Yun SP; Park JI; Jung BH; Shin DH; Choi YI; Moon HH; Chu CW; Ryu JH; Yang K; Park YM; Hong SC
    Surgery; 2017 Sep; 162(3):515-524. PubMed ID: 28629653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma.
    Buettner S; Margonis GA; Kim Y; Gani F; Ethun CG; Poultsides GA; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2016 Dec; 23(13):4401-4409. PubMed ID: 27495279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study).
    Bergquist JR; Shah HN; Habermann EB; Hernandez MC; Ivanics T; Kendrick ML; Smoot RL; Nagorney DM; Borad MJ; McWilliams RR; Truty MJ
    Int J Surg; 2018 Apr; 52():171-179. PubMed ID: 29496648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative Radiation Therapy for Gallbladder Cancer: Experience at a Single Institution.
    Lee NK; Kim CY; Park YJ; Yang DS; Yoon WS; Suh SO
    Hepatogastroenterology; 2014 May; 61(131):580-6. PubMed ID: 26176039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining Early Recurrence of Hilar Cholangiocarcinoma After Curative-intent Surgery: A Multi-institutional Study from the US Extrahepatic Biliary Malignancy Consortium.
    Zhang XF; Beal EW; Chakedis J; Chen Q; Lv Y; Ethun CG; Salem A; Weber SM; Tran T; Poultsides G; Son AY; Hatzaras I; Jin L; Fields RC; Buettner S; Scoggins C; Martin RCG; Isom CA; Idrees K; Mogal HD; Shen P; Maithel SK; Schmidt CR; Pawlik TM
    World J Surg; 2018 Sep; 42(9):2919-2929. PubMed ID: 29404753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of radical surgery in patients with stage IV gallbladder cancer.
    Kang MJ; Song Y; Jang JY; Han IW; Kim SW
    HPB (Oxford); 2012 Dec; 14(12):805-11. PubMed ID: 23134181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis.
    Kim Y; Amini N; Wilson A; Margonis GA; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Cardona K; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2016 Sep; 23(9):2998-3008. PubMed ID: 27169772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early recurrence of well-differentiated (G1) neuroendocrine liver metastasis after curative-intent surgery: Risk factors and outcome.
    Xiang JX; Zhang XF; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
    J Surg Oncol; 2018 Dec; 118(7):1096-1104. PubMed ID: 30261105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium.
    Lopez-Aguiar AG; Ethun CG; McInnis MR; Pawlik TM; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick BA; Weber SM; Salem A; Martin RCG; Scoggins CR; Shen P; Mogal HD; Schmidt C; Beal EW; Hatzaras I; Shenoy R; Cardona K; Maithel SK
    J Surg Oncol; 2018 Jun; 117(8):1638-1647. PubMed ID: 29761515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Surgical Methods and Tumor Location on Survival and Recurrence Patterns after Curative Resection in Patients with T2 Gallbladder Cancer.
    Jung W; Jang JY; Kang MJ; Chang YR; Shin YC; Chang J; Kim SW
    Gut Liver; 2016 Jan; 10(1):140-6. PubMed ID: 26347513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
    Jarnagin WR; Ruo L; Little SA; Klimstra D; D'Angelica M; DeMatteo RP; Wagman R; Blumgart LH; Fong Y
    Cancer; 2003 Oct; 98(8):1689-700. PubMed ID: 14534886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival Analysis of Cancer Patients With FIGO Stage IIIA Endometrial Cancer.
    Lum MM; Belnap TW; Frandsen J; Brown AP; Sause WT; Soisson AP; Dodson MK; Werner T; Gaffney DK
    Am J Clin Oncol; 2015 Jun; 38(3):283-8. PubMed ID: 23774072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidental Gallbladder Cancer: Residual Cancer Discovered at Oncologic Extended Resection Determines Outcome: A Report from High- and Low-Incidence Countries.
    Vinuela E; Vega EA; Yamashita S; Sanhueza M; Mege R; Cavada G; Aloia TA; Chun YS; Lee JE; Vauthey JN; Conrad C
    Ann Surg Oncol; 2017 Aug; 24(8):2334-2343. PubMed ID: 28417239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of neoadjuvant chemotherapy in "locally advanced/borderline resectable" gallbladder cancer: the need to define indications.
    Chaudhari VA; Ostwal V; Patkar S; Sahu A; Toshniwal A; Ramaswamy A; Shetty NS; Shrikhande SV; Goel M
    HPB (Oxford); 2018 Sep; 20(9):841-847. PubMed ID: 29706425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.